A Pilot Study to Evaluate Effectiveness of Botulinum Toxin in Treatment of Androgenetic Alopecia in Males

    Sehdev Singh, Shekhar Neema, Biju Vasudevan
    New to Botox? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary In this pilot study, botulinum toxin was found to be a safe and effective treatment for androgenetic alopecia in most participants, though larger studies are needed to confirm these findings.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    In a pilot study conducted in 2017, botulinum toxin was found to be a safe and effective treatment for androgenetic alopecia in males. The study involved 10 male patients with androgenetic alopecia, who were injected with 5 U of botulinum toxin at 30 sites in the scalp. The efficacy of the treatment was assessed through photographic assessment and self-assessment scoring by the patients after 24 weeks. The results showed that 8 out of 10 patients had a good to excellent response based on photographic assessment, while 7 out of 10 patients reported a good to excellent response based on self-assessment. However, the study concluded that further research with a larger sample size and randomized controlled trials are needed to establish the role of botulinum toxin in the management of androgenetic alopecia.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results